FDA Approved: ZTALMY — Original Application (Immedica Pharma US Inc)

View source ↗

Summary

The FDA approved ZTALMY (ganaxolone) from Immedica Pharma US Inc as an original new drug application for the treatment of seizures associated with CDKL5 deficie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cdkl5 Deficiency Disorder

Drugs mentioned

• ZTALMY (ganaxolone)

Snippet

ORIG AP for ZTALMY (GANAXOLONE)